GSK (GSK) Files Form 6K on April 2 with Key Updates

GSK plc (GSK) submitted a Form 6K on April 2, outlining recent developments. This form typically includes important disclosures that can impact investor perceptions and decisions. The filing may provide insights into GSK's future strategies, collaborations, or financial health. Monitoring these updates is essential for understanding how they may influence GSK's stock performance moving forward.